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An RNA 59-Triphosphatase Related
to the Protein Tyrosine Phosphatases
Toshimitsu Takagi, Christine R. Moore, Felix Diehn, Only a few eukaryotic capping enzyme genes have
been cloned to date, all from yeast. In addition to theand Stephen Buratowski
Department of Biological Chemistry and Molecular yeast methyltransferase gene ABD1, three yeast guany-
lyltransferase genes have been described. The S. cere-Pharmacology
Harvard Medical School visiae guanylyltransferase is encoded by CEG1 (Shiba-
gaki et al., 1992). By complementation of mutant CEG1Boston, Massachusetts 02115
alleles, guanylyltransferases for two other yeasts have
been cloned (Shuman et al., 1994; Yamada-Okabe etSummary
al., 1996; L. D. Fresco et al., unpublished data). Both
CEG1 and ABD1 are essential for viability. SequencemRNA capping requires the sequential action of three
analysis, biochemical characterization, and genetic ex-enzymatic activities: RNA triphosphatase, guanylyl-
periments have shown that the yeast guanylyltransfer-transferase, and methyltransferase. Here we charac-
ases aremechanistically related toDNA and RNA ligasesterize agene (CEL-1) believed to encode theC. elegans
(Shuman and Schwer, 1995, for review). The yeast gua-capping enzyme. CEL-1 has a C-terminal domain con-
nylyltransferase proteins do not have RNA 59-triphos-taining motifs found in yeast and vaccinia virus cap-
phatase activity.ping enzyme guanylyltransferases. The N-terminal
There are two major gaps in our understanding ofdomain of CEL-1 has RNA triphosphatase activity. Sur-
capping enzymes. First, since the yeast triphosphataseprisingly, this domain does not resemble the vaccinia
subunit gene has not yet been identified, little is knownvirus capping enzyme but does have significant se-
about the enzymology of the eukaryotic triphosphatasequence similarity to the protein tyrosine phosphatase
reaction. Second, no genes for higher eukaryotic cap-(PTP) enzyme family. However, CEL-1 has no detect-
ping enzymes, which combine both triphosphatase andable PTP activity. The mechanism of the RNA triphos-
guanylyltransferase activities in one protein, have yetphatase is similar to that of PTPs: the active site con-
been described. In this report, we present the cloningtains a conserved nucleophilic cysteine required for
and characterization of the putative C. elegans cappingactivity. These results broaden the superfamily of PTP-
enzyme gene. Remarkably, this enzyme appears to con-like phosphatases to include enzymes with RNA sub-
sist of two domains: one that is closely related to thestrates.
yeast guanylyltransferases and a second that is a mem-
ber of the protein tyrosine phosphatase (PTP) superfam-Introduction
ily. The PTP domain has no tyrosine phosphatase activ-
ity, yet apparently uses a mechanism similar to PTPs toTranscripts produced by RNA polymerase II are modi-
remove the terminal phosphate of mRNA.fied at their 59 end by the addition of a 7-methyl guano-
sine cap. Capping is the earliest modification of mRNA,
occurring by the time the transcript is 25±30 nucleotides Results
long (Jove and Manley, 1984; Rasmussen and Lis, 1993).
The reaction occurs in three steps (see Figure 1): an To find higher eukaryotic capping enzymes, we carried
out a search for genes with significant similarity to theRNA 59-triphosphatase removes the gamma phosphate
at the 59 end of the transcript, a GTP::RNA guanylyltrans- yeast guanylyltransferases using the BLAST algorithm
(Altschul et al., 1990). A strong match was found to aferase adds a GMP residue to the 59 diphosphate end
ina 59-to-59 orientation, and an RNA (guanine-7-) methyl- gene (C03D6.3, GenBank accession no. Z75525) that
emerged from the C. elegans genome sequencing proj-transferase adds the methyl group to the guanine (see
Mizumoto and Kaziro, 1987, for review). ect. The predicted open reading frame of this gene is
573 amino acids. The C-terminal 340 amino acids of theBiochemical purifications of capping enzymes from
various organisms have revealed differences in subunit protein exhibit very strong sequence similarity to the
yeast guanylyltransferases (Figure 2A), particularly instructure between organisms (Mizumoto and Kaziro,
1987). Vaccinia virus encodes its own capping enzyme, regions previously noted to be conserved between eu-
karyotic and viral capping enzyme guanylyltransferaseswhich consists of two subunits. The larger subunit has
both triphosphatase and guanylyltransferase activities, (Shuman and Schwer, 1995, for review). The C. elegans
protein contains a motif containing the nucleophilic ly-while both subunits are required to reconstitute methyl-
transferase activity (Shuman, 1990). Biochemical char- sine required for formation of the enzyme-GMP interme-
diate of the capping reaction (marked by an asterisk inacterization of capping enzymes from higher eukaryotes
suggest that there is one protein carrying both triphos- Figure 2A).
The C. elegans capping enzyme has not been pre-phatase and guanylyltransferase activities. In contrast
to higher eukaryotes, the Saccharomyces cerevisiae viously studied. Extracts from C. elegans were incu-
bated with [a-32P]GTP in order to allow formation of thecapping enzyme has two subunits: a 53 kDa guanylyl-
transferase and an 80 kDa triphosphatase subunit (Itoh guanylyltransferase-GMP covalent intermediate (see
Figure 1). The major labeled band was about 68 kDaet al., 1984a, 1987). The yeast methyltransferase purifies
as an unassociated enzyme and is encoded by the gene (data not shown), in excellent agreement with the pre-
dicted molecular weight of C03D6.3. We attempted toABD1 (Mao et al., 1995).
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strong sequence alignment and data presented below,
we believe that this protein encodes the C. elegans cap-
ping enzyme. Accordingly, we have tentatively desig-
nated this gene CEL-1, for Capping Enzyme from C.
elegans. However, definitive proof of the guanylyltrans-
ferase activity remains to be shown.
CEL-1 Contains a PTP-like Domain
Figure 1. Enzymatic Steps in the mRNA Capping Reaction In addition to the region homologous to yeast guanylyl-
pppNN- represents the 59 end of the nascent RNA transcript; GT transferase, the C. elegans protein has an additional
stands for the mRNA guanylyltransferase; AdoMet is S-adenosyl
N-terminal region of approximately 230 amino acids.methionine; and AdoHcy is S-adenosyl homocysteine (Mizumoto
This region was of particular interest, since cappingand Kaziro, 1987, for review).
enzymes purified from some higher eukaryotes have
been shown to carry both triphosphatase and guanylyl-
transferase activities on one peptide (Mizumoto andexpress recombinant protein in bacteria or reticulocyte
lysates, but have so far been unable to detect guanylyl- Kaziro, 1987, for review). A search of the sequence data-
bases using amino acids 1±240 of CEL-1 led to thetransferase activity. C03D6.3 may be toxic in bacteria,
since sequencing of several independent clones re- remarkable finding that this region of the protein was
quite similar to the protein tyrosine phosphatase proteinvealed missense and premature termination mutations
in the guanylyltransferase-like region. Based on the family (Figure 2B). In particular, the conserved active
Figure 2. CEL-1 Is Related to Guanylyltransferases and Protein Tyrosine Phosphatases
(A) Alignment between CEL-1 andyeast guanylyltransferases. The deduced amino acidsequence of CEL-1 is compared with guanylyltransferase
subunits of the S. cerevisiae (CEG1; Shibagaki et al., 1992) and S. pombe (PCE1; Shuman et al., 1994) mRNA capping enzyme. Letters represent
the single-letter amino acid code, and numbers represent the positions of the amino acid residues. The asterisk shows the guanylyltransferase
active site lysine residue (Shuman and Schwer, 1995). Boxed residues denote identities, and shaded residues signify similarity to the CEL-1
amino acid sequence.
(B) Alignment between N-terminal region of CEL-1 and protein tyrosine phosphatases. The following sequences are shown: CEL-1 (residues
1±200 of C. elegans gene C03D6.3); BVP (Baculovirus PTP [Sheng and Charbonneau, 1993]); T23G7.5, F54C8.4 (two other C. elegans open
reading frames, GenBank accession nos. Z68319 and Z22178). The active site consensus of PTPs is marked by a line while the asterisk shows
the predicted phosphatase active site cysteine residue (Denu et al., 1996; Fauman and Saper, 1996).
(C) Schematic representation of the CEL-1 domain structure.
PTP-like RNA Triphosphatase
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Figure 4. The CEL-1 Triphosphatase Leaves a Diphosphate End
A two-step reaction was performed as described in Experimental
Procedures. In the first step, GTP-terminated RNA was incubated
with the indicated enzyme preparations labeled as in Figure 3. After
the first incubation, RNA was purified and subjected to a second
incubation with [a-32P]GTP and recombinant guanylyltransferase
subunit of S. cerevisiae capping enzyme. RNA was extracted,
treated with nuclease P1 and CIP, and the cap structure was ana-
lyzed by paper electrophoresis and PhosphorImager. The position
of an authentic cap structure sample (GpppG) was detected by UV
light.
Z22178). The closest non±C. elegans match was to a
baculovirus tyrosine phosphatase that also has the abil-
ity to remove phosphate from serine and threonine
(Sheng and Charbonneau, 1993).
The CEL-1 PTP-like Domain Is an RNA
59-Triphosphatase but Not
a Tyrosine Phosphatase
Based on the similarity to protein tyrosine phospha-
tases, two possible functions of the CEL-1 PTP-like do-
main were considered. Our primary hypothesis was that
the PTP-like domain of CEL-1 was the mRNA triphos-
Figure 3. The CEL-1 Amino-Terminal Domain Is an RNA Triphos-
phatase necessary for the first step in capping. How-phatase
ever, PTP domains often appear fused to other func-(A) 59 RNA triphosphatase assay. [g-32P]GTP-terminated RNA was
tional domains such as transmembrane receptors andincubated with buffer (lane 1); 50 ng of vaccinia virus capping en-
zyme (VV, lane 2); 1 unit of calf intestinal phosphatase (CIP, lane 3); SH2 domains (Denu et al., 1996; Fauman and Saper,
or 10 ng of his7-Cel-1(1±236) (lane 5). Lane 4 (mock) is a negative 1996). Therefore, a second possibility was that the
control that has 10 ng of protein from an extract made from E. coli CEL-1 PTP-like domain was a true tyrosine phosphatase
strain BL21(DE3) transformed with vector and chromatographed in
involved in regulation of capping enzyme or some otherparallel with the CEL-1 extract. Incubation was for 30 min at 308C
associated protein. To test these hypotheses, recombi-(lanes 1, 4, and 5) or 378C (lanes 2 and 3). The reaction mixture
was analyzed by thin-layer chromatography (TLC) on PEI-cellulose nant protein encompassing residues 1±236 was ex-
plates. 32P label was detected by PhosphorImager. pressed in E. coli and purified to apparent homogeneity
(B) Nucleotide phosphohydrolase assay. Reactions in lanes 1±5 (data not shown).
were identical to those in (A), except [g-32P]GTP-terminated RNA
The recombinant CEL-1 amino terminal domain waswas replaced with [g-32P]GTP.
tested for tyrosine phosphatase activity. Two commonly
used tyrosine phosphatase assays were used. The firstsite motif (I/V)HCxxGxxR(S/T)G of protein tyrosine phos-
was to test for release of phosphate from myelin basicphatases (Denu et al., 1996; Fauman and Saper, 1996)
protein phosphorylated on tyrosine. Although a bonawas matched by residues 122±132 (overlined in Figure
fide T-cell PTP released phosphate from myelin basic2B). Most alignments between CEL-1 and tyrosine phos-
protein, the CEL-1 protein was completely inactive inphatases revealed some additional conserved residues
this assay (data not shown). The second assay testedflanking the active site region. Particularly extensive
the ability to hydrolyze 4-nitrophenyl phosphate (pNPP),alignments (p , 10215) were found with two other C.
a chromogenic substrate analog of phosphotyrosine. Allelegans open reading frames (T23G7.5, GenBank acces-
sion no. Z68319 and F54C8.4, GenBank accession no. true tyrosine phosphatases tested to date are able to
Cell
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(which has no triphosphatase activity) and [a-32P]GTP.
The reactions were then assayed for the presence of
the labeled GpppG cap structure. Only the VV capping
enzyme and the CEL-1 triphosphatase produced RNA
substrates with diphosphate ends that could be guany-
lylated (Figure 4, lanes 2 and 5). Therefore, the CEL-1
amino-terminal domain exhibits all the enzymatic activi-
ties necessary for a capping enzyme triphosphatase.
Conservation of Mechanism between the RNA
Triphosphatase and PTPs
Because the sequence similarity between CEL-1 and
PTPs spans the PTP active site, it seemed likely that the
two types of enzymes would share some mechanistic
Figure 5. The CEL-1 RNA Triphosphatase Requires the PTP Active features. PTPs have been extensively studied in terms
Site Cysteine of both enzyme mechanism and structure (Denu et al.,
An RNA triphosphatase assay was performed with his7-Cel-1(1±236) 1996; Fauman and Saper, 1996). The conservedcysteine
or his7-Cel-1(1±236)C124S. After the incubation, the reaction mix- of the PTPs acts as a nucleophile to attack the phos-ture was processed by PEI cellulose thin-layer chromatography.
phate, forming a transient phosphocysteine intermedi-[g-32P]GTP-terminated RNA was incubated either with buffer (lane
1), the indicated amounts of wild-type his7-Cel-1(1±236)(lanes 2±4), ate. The tyrosine and attached protein are the leaving
or mutant his7-Cel-1(1±236)C124S (lanes 5±7). A mutant with the group. A feature of PTPs that distinguishes them from
amino acid change C124A behaved identically to the C124S mutant many other phosphatases is that they do not require
(data not shown). divalent cations (Denu et al., 1996; Fauman and Saper,
1996). The CEL-1 triphosphatase activity was tested at
varying magnesium concentrations. No divalent cationshydrolyze this substrate (Denu et al., 1996; Fauman and
were necessary for triphosphatase activity (data notSaper, 1996). As in the first assay, the CEL-1 PTP-like
shown), as would be predicted from a PTP-like mech-domain exhibited no activity (data not shown). There-
anism.fore, it appears very unlikely that CEL-1 is a true protein
By alignment of CEL-1 with the PTP active site con-tyrosine phosphatase.
sensus, we predicted that the CEL-1 RNA triphospha-To test the CEL-1 amino-terminal domain for RNA
tase should use cysteine 124 as a nucleophile to attacktriphosphatase activity, the protein was incubated with
the g-phosphate at the mRNA 59 end (marked by ana synthetic RNA terminated by a 59 triphosphate end
asterisk in Figure 2B). To test whether C124 was essen-labeled with a [32P]g-phosphate. Release of monophos-
tial for RNA triphosphatase activity, we mutated thisphate was assayed by thin layer chromatography (Figure
residue to serine or alanine. The wild-type and mutant3A). Control reactions with calf intestinal phosphatase
N-terminal domains were produced in bacteria and(CIP, lane 3) and vaccinia virus capping enzyme (VV, lane
tested for RNA triphosphatase activity (Figure 5). The2) released monophosphate from the RNA substrate. As
C124S mutant (lanes 5±7) and the C124A mutant (datawould be expected for a bona fide capping enzyme, the
not shown) proteins were not functional, suggesting thatCEL-1 amino-terminal domain also showed RNA tri-
the capping enzyme RNA triphosphatase uses a mecha-phosphatase activity (lane 5). The T-cell PTP used as a
nism very similar to that of protein tyrosine phospha-positive control in the tyrosine phosphatase assays had
tases.no detectable RNA triphosphatase activity (data not
shown).
To see whether this triphosphatase activity was spe- Discussion
cific for polynucleotide RNA, the same experiment was
carried out using [g-32P]GTP (Figure 3B) or ATP (data Surprisingly, the CEL-1 RNA triphosphatase is related
to the family of protein tyrosine phosphatases. This en-not shown). In this case, CIP (lane 3) completely released
the labeled phosphate, while the vaccinia virus capping zyme family consists of both tyrosine-specific phospha-
tases as well as ªdual specificityº tyrosine phosphatasesenzyme (VV, lane 2) had weak GTPase activity as pre-
viously described (Shuman et al., 1980; Myette and that also hydrolyze phosphoserine and phosphothreo-
nine to some extent (reviewed in Denu et al., 1996; Fau-Niles, 1996). However, CEL-1 released no monophos-
phate (lane 5), demonstrating that the CEL-1 triphospha- man and Saper, 1996). PTPs have been implicated in
several processes, including signal transduction andtase is specific for polynucleotide RNA as expected for
a cellular mRNA capping enzyme (Yagi et al., 1983). cell cycle control. CEL-1 represents the first member of
this family to recognize an RNA substrate. There areFor the CEL-1 amino-terminal domain to function in
the capping reaction, it must leave a diphosphate 59 end a number of genes (including CEL-1) emerging from
genome sequencing projects that are listed in the data-to serve as the substrate for the subsequent guanylyl-
transferase. This was tested in a two step reaction. First, bases as tyrosine phosphatases. The discovery that this
family of enzymes has a wider than anticipated substratea 59 triphosphate±ended RNA was incubated with CEL-1
triphosphatase, VV capping enzyme, CIP, or no enzyme. range underscores the need for experimental confirma-
tion of functional assignments based on sequence ho-The reaction was then deproteinized and the resulting
RNA was incubated with yeast guanylyltransferase mology alone. Indeed, there are several receptor-like
PTP-like RNA Triphosphatase
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PTP proteins that carry two PTP domains, one of which antiviral or antifungal agents with limited effect on the
host enzyme.is often inactive on phosphotyrosine (reviewed in Denu
et al., 1996; Fauman and Saper, 1996). These ``inactive''
domains may in fact have other substrates that have Experimental Procedures
not yet been recognized.
DNA Cloning MethodsThe C. elegans capping enzyme triphosphatase is
The CEL-1 open reading frame was amplified by AmpliTaq polymer-most closely related to the baculovirus protein BVP
ase (Perkin Elmer) in a polymerase chain reaction (PCR) using a(Sheng and Charbonneau, 1993). This protein has been C. elegans oligo-dT-primed cDNA library kindly donated by the G.
experimentally shown to have potent tyrosyl and seryl/ Ruvkun lab (Massachusetts General Hospital). Oligonucleotide
threonyl phosphatase activities. Based on its sequence primer sequences were as follows: top strand 59GCGGATCCATGGG
ACTGCCTGATAGATGGCTGCA39, bottom strand 59GCGGATCCTsimilarity, it would be interesting to test this protein for
CACTCAATTAAATAGGTTTCAGTGAC39.RNA triphosphatase activity as well. A T-cell PTP was
The PCR reaction introduced an NcoI site at the initiation codontested and had no RNA triphosphatase activity (data not
and BamHI sites at both ends of the fragment. The 1.775 kb fragment
shown). Two other open reading frames with significant was cloned into pCR-Script SK1 (Stratagene) to generate pBS-
sequence similarity to CEL-1 and BVP have also CEL-1. A 1.75 kb NcoI±BamHI fragment was then excised and
emerged from the C. elegans genome sequencing proj- cloned into the NcoI±BamHI sites of pET11-his7, a modified version
of pET11d (Novagen) that contains a cassette coding for sevenect. The proteins encoded by these genes have not yet
histidines at the N-terminus of the protein. The resulting plasmidbeen tested for substrate specificity. These four proteins
was cut with BstBI and BamHI, blunted, and religated to removeapparently represent a distinct branch of the PTP en-
the C-terminal BstBI-BamHI fragment. The resulting plasmid en-zyme superfamily, as their similarity to other PTPs is
codes the N-terminal 236 amino acids of CEL-1.
largely confined to the active site consensus sequence. Oligonucleotide-directed mutagenesis of the the cysteine 124 co-
don was carried out on single-stranded phagemid from pBS-CEL-1
as described (Kunkel et al., 1987; Vieira and Messing, 1987). TheCapping Enzyme Triphosphatases
oligo was designed to change the cysteine codon to that for eitherIt remains to be seen whether the CEL-1 triphosphatase
serine or alanine. Mutations were identified by dideoxy-DNA se-is representative of all higher eukaryotic capping en-
quencing. The NcoI-BstB1 fragments from the mutant plasmids
zymes. Biochemical characterizations of capping en- were then cloned into the NcoI and ClaI sites of the pET11-his7 to
zymes from two higher eukaryotes (brine shrimp and produce bacterial expression plasmids.
rat) are consistent with a single protein with both triphos-
phatase and guanylyltransferase activity, although the Recombinant Protein Production and Purification
genes for these proteins have not yet been cloned (re- Polyhistidine-tagged N-terminal portion of CEL-1 protein [his7-
Cel-1(1±236)] was expressed using a T7 promoter/polymerase sys-viewed in Mizumoto and Kaziro, 1987). In yeast, the
tem in E. coli strain BL21(DE3) (Studier et al., 1990). Strains carryingcapping enzyme mRNA triphosphatase is a separate
bacterial expression plasmids were grown at 308C to an OD600 5 0.5polypeptide from the guanylyltransferase, although the
and induced by the addition of 0.4 mM IPTG. Cells were further
two proteins are associated (Itoh et al., 1984a, 1987). A cultured for 3 hr at 308C and harvested. Lysates were prepared by
comparison of all yeast protein sequences with the sonication, and soluble extracts were incubated in batch with Ni21-
CEL-1 triphosphatase domain revealed moderate NTA-agarose resin (Qiagen) overnight on a rotator at 48C. The resin
was extensively washed with buffer A (20 mM HEPES±KOH [pH 7.9],matches to several proteins in the PTP family, particu-
100 mM KCl, 10% (v/v) glycerol, 2 mM b-mercaptoethanol, 1 mMlarly CDC14. However, none of the alignments were par-
phenylmethylsulfonyl fluoride [PMSF]) containing 15 mM imidazoleticularly extensive and the predicted sizes of the pro-
and then was poured into a column. Bound protein was eluted with
teins were not in close agreement with the 80 kDa size buffer A containing 600 mM imidazole. Fractions were collected
of purified triphosphatase (Itoh et al., 1987). and dialyzed overnight at 48C against 500 vol of buffer B (20 mM
It is possible that the yeast triphosphatase is not re- HEPES±KOH [pH 7.9], 1 mM EDTA, 10% (v/v) glycerol, 1 mM DTT,
1 mM PMSF) containing 30 mM KCl. his7-Cel-1(1±236) was furtherlated to CEL-1 or the PTP enzymes. The yeast RNA
purified by column chromatography over Heparin Sepharose CL-triphosphatase requires divalent cations for activity (Itoh
6B (Pharmacia) using a gradient of 30±600 mM KCl in buffer B.et al., 1984b), which is a property of many classes of
Proteins were monitored by SDS±PAGE and Coomassie blue stain-
phosphatases, but not of PTPs. CEL-1 triphosphatase ing. his7-Cel-1(1±236) eluted at 100 mM KCl. To provide a ªmockº
was not inhibited by EDTA and was strongly inhibited negative control, soluble extract was prepared from BL21(DE3) har-
(.90%) by the presence of 2 mM Mg21 (data not shown). boring pET11-his7 and was chromatographed as described above.
Recombinant vaccinia virus capping enzyme was produced asSimilar results have been described for the rat liver cap-
follows. E. coli strain BL21(DE3) (Studier et al., 1990) was trans-ping enzyme (Yagi et al., 1983). In contrast, the vaccinia
formed with plasmid pETD12D1 (Guo and Moss, 1990; a gift fromvirus RNA triphosphatase requires divalent cations
Dr. B. Moss, NIH), which expresses both subunits of the enzyme.
(Shuman, 1990; Myette and Niles, 1996). The vaccinia Recombinant VV capping enzyme was partially purified from the
virus capping enzyme does not show obvious sequence soluble fraction through successive columns of DE52 (Whatman),
similarity to tyrosine phosphatases (Niles et al., 1986; P11 (Whatman), single-stranded DNA cellulose (Pharmacia), and
Heparin Sepharose CL-6B. Activity was assayed by formation ofYu and Shuman, 1996). Indeed, there are no obvious
enzyme-GMP complex as described (Guo and Moss, 1990).similarities to any of the known phosphatase families.
Therefore, it may be that distinct enzymatic mecha-
Tyrosine Phosphatase Assaysnisms may carry out similar phosphatase reactions in
Protein tyrosine phosphatase activity was assayed using a commer-different capping enzymes. This is in contrast to the
cially available assaykit (New England Biolabs). 32P-tyrosine-labeled
guanylyltransferases, which appear to use a common myelin basic protein was prepared with [g-32P]ATP (NEN/DuPont)
enzymatic mechanism (Shuman and Schwer, 1995). and release of phosphate was monitored as suggested by the manu-
Such major mechanistic differences suggest that inhibi- facturer. For the hydrolysis of 4-nitrophenyl phosphate (pNPP), 100
ng of the indicated protein was mixed with 10 mM pNPP, 50 mMtors of the viral or yeast triphosphatases could act as
Cell
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